Tag: Tempus AI
Tempus reads lung tumour slides to sort who needs which test
A Tempus panel squeezed above 80% sensitivity on all 12 lung cancer biomarkers using nothing but routine H&E slides.
Tempus adds a leaky heart valve to what an ECG can flag
Tempus won clearance for software that reads a routine heart tracing for signs of undiagnosed mitral regurgitation.
Tempus AI acquires Personalis for $1.5B in precision medicine play
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.